These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Tümen D; Heumann P; Gülow K; Demirci CN; Cosma LS; Müller M; Kandulski A Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551958 [TBL] [Abstract][Full Text] [Related]
4. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma]. Fares N; Péron JM Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937 [TBL] [Abstract][Full Text] [Related]
6. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan. Kee KM; Lu SN Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease. Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795 [TBL] [Abstract][Full Text] [Related]
8. Management strategies for hepatocellular carcinoma: old certainties and new realities. Mazzoccoli G; Tarquini R; Valoriani A; Oben J; Vinciguerra M; Marra F Clin Exp Med; 2016 Aug; 16(3):243-56. PubMed ID: 26077653 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic ultrasound and fine-needle aspiration for the diagnosis of hepatocellular carcinoma. Maheshwari A; Kantsevoy S; Jagannath S; Thuluvath PJ Clin Liver Dis; 2010 May; 14(2):325-32. PubMed ID: 20682238 [TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. Han K; Kim JH World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959 [TBL] [Abstract][Full Text] [Related]
12. Advances in management of hepatocellular carcinoma. Allaire M; Nault JC Curr Opin Oncol; 2017 Jul; 29(4):288-295. PubMed ID: 28509806 [TBL] [Abstract][Full Text] [Related]
13. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009 [TBL] [Abstract][Full Text] [Related]
14. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma. Tanase AM; Dumitrascu T; Dima S; Grigorie R; Marchio A; Pineau P; Popescu I Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):162-72. PubMed ID: 24686543 [TBL] [Abstract][Full Text] [Related]
15. Etiological and molecular profile of hepatocellular cancer from India. Asim M; Sarma MP; Kar P Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429 [TBL] [Abstract][Full Text] [Related]
16. Aflatoxin B Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866 [TBL] [Abstract][Full Text] [Related]
17. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia. Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951 [TBL] [Abstract][Full Text] [Related]
18. Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis. Guan X; Xing F; Li Y Eur J Gastroenterol Hepatol; 2021 Sep; 33(9):1218-1221. PubMed ID: 32658012 [TBL] [Abstract][Full Text] [Related]
19. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C. Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058 [TBL] [Abstract][Full Text] [Related]
20. The epidemiology and prevention of hepatocellular carcinoma. Monto A; Wright TL Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]